We are live on ! Find out more
IHI icon

iShares US Medical Devices ETF

585 hedge funds and large institutions have $2.19B invested in iShares US Medical Devices ETF in 2023 Q2 according to their latest regulatory filings, with 68 funds opening new positions, 168 increasing their positions, 233 reducing their positions, and 38 closing their positions.

New
Increased
Maintained
Reduced
Closed

79% more first-time investments, than exits

New positions opened: 68 | Existing positions closed: 38

5% more funds holding

Funds holding: 557585 (+28)

0% more funds holding in top 10

Funds holding in top 10: 1515 (0)

4% less capital invested

Capital invested by funds: $2.28B → $2.19B (-$81.5M)

2.34% less ownership

Funds ownership: 38.08%35.74% (-2.3%)

28% less repeat investments, than reductions

Existing positions increased: 168 | Existing positions reduced: 233

32% less call options, than puts

Call options by funds: $12.4M | Put options by funds: $18.1M

Holders
585
Holders Change
+28
Holders Change %
+5.03%
% of All Funds
9.19%
Holding in Top 10
15
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.24%
New
68
Increased
168
Reduced
233
Closed
38
Calls
$12.4M
Puts
$18.1M
Net Calls
-$5.71M
Net Calls Change
-$14M
Name Holding Trade Value Shares
Change
Change in
Stake
Cetera Investment Advisers
126
Cetera Investment Advisers
Illinois
$2.35M -$411K -7,462 -15%
RHP
127
Royal Harbor Partners
Texas
$2.33M +$2.28M +41,355 New
MMA
128
Miracle Mile Advisors
California
$2.32M -$2.48M -44,960 -52%
CAM
129
Cypress Asset Management
Texas
$2.29M -$66.1K -1,200 -3%
PA
130
Parallel Advisors
California
$2.29M -$528K -9,593 -19%
P
131
Palladiem
Pennsylvania
$2.19M +$110 +2 +0%
SWP
132
Stratos Wealth Partners
Ohio
$2.16M +$155K +2,808 +8%
Creative Planning
133
Creative Planning
Kansas
$2.14M +$922K +16,739 +79%
WA
134
WESPAC Advisors
California
$2.13M +$225K +4,092 +12%
AIA
135
Armor Investment Advisors
North Carolina
$2.08M -$53.5K -972 -3%
MBT
136
Montecito Bank & Trust
California
$2.05M -$19.1K -347 -0.9%
EFH
137
Eaton Financial Holdings
Florida
$1.99M +$17.9K +325 +0.9%
PA
138
Pinnacle Associates
New York
$1.98M +$60.6K +1,100 +3%
SI
139
Stephens Inc
Arkansas
$1.98M +$1.4M +25,390 +263%
SS
140
Sunbelt Securities
Texas
$1.94M -$99.7K -1,810 -5%
CWM
141
Concentrum Wealth Management
California
$1.9M +$18K +326 +1%
GPA
142
Garrison Point Advisors
California
$1.88M -$4.57K -83 -0.2%
BCM
143
Brookstone Capital Management
Illinois
$1.88M +$498K +9,039 +36%
IAN
144
Integrated Advisors Network
Texas
$1.87M +$42.4K +769 +2%
CWM
145
C2C Wealth Management
Arizona
$1.84M
DWM
146
Destination Wealth Management
California
$1.83M -$75.3K -1,367 -4%
KF
147
Krilogy Financial
Missouri
$1.83M +$1.78M +32,326 New
JWCA
148
J.W. Cole Advisors
Florida
$1.81M -$157K -2,844 -8%
Mirae Asset Global Investments
149
Mirae Asset Global Investments
South Korea
$1.81M +$600K +10,900 +52%
CA
150
Cetera Advisors
Colorado
$1.81M -$134K -2,425 -7%

IHI Hedge Fund Activity: Q2 2023 in Review

585 of the 6,369 institutional investors tracked by Wall St. Rank reported a position in iShares US Medical Devices ETF (IHI) for Q2 2023, worth a combined $2.19B — down 3.6% from $2.28B a quarter earlier.

Buyers outnumbered sellers: 68 funds opened new IHI positions and 38 closed out — a net gain of 30 holders — while 168 added to existing stakes and 233 trimmed.

The largest buyer was LPL Financial, adding an estimated $13.5M. The largest seller was Menora Mivtachim Holdings, exiting entirely with an estimated $107M sold.

  • 585 institutional investors held iShares US Medical Devices ETF (IHI) as of Q2 2023, up from 557 in Q1 2023.
  • Funds reported $2.19B of iShares US Medical Devices ETF stock for Q2 2023, down 3.6% quarter-over-quarter.
  • 68 funds opened new iShares US Medical Devices ETF positions in Q2 2023 and 38 closed out, a net change of +30 holders.
  • The largest iShares US Medical Devices ETF buyer in Q2 2023 was LPL Financial, an estimated $13.5M added.
  • The largest iShares US Medical Devices ETF seller in Q2 2023 was Menora Mivtachim Holdings, an estimated $107M sold.

Based on aggregated 13F filings for Q2 2023.